We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Found to Limit Damage of Acute Brain Injury

By Biotechdaily staff writers
Posted on 31 Jul 2003
Scientists have identified a protein with the ability to limit nuerologic damage induced by stroke or trauma and thereby has the potential to improve the long-term outcome of acute brain injury. More...
Their findings were reported in the July 13, 2003, online issue of Nature Medicine.

In the process of identifying new mechanisms of brain protection by using a genomics approach, the researchers found the gene encoding uncoupling protein-2 (UCP-2) to be up-regulated in response to short episodes of reduced blood flow. Further analysis revealed that UPC-2 displayed a marked neuroprotective effect in experimental mouse models of stroke and brain trauma and in vitro models of neuronal death, indicating that UCP-2 is potentially protective against human stroke and brain trauma. The research was conducted by AGY Therapeutics, Inc. (So. San Francisco, CA, USA; www.agyinc.com), in collaboration with scientists at the Wallenberg Neuroscience Center (Sweden), the State University of Campinas (Brazil), and the University of California, Davis (USA).

"Following stroke or serious head injury, a cascade of events is initiated in the vicinity of the damage that results in the programmed cell death of neurons, which is responsible for many of the long-term debilitating effects of brain trauma,” said Karoly Nikolich, Ph.D., founder and chief scientific officer, AGY Therapeutics.”




Related Links:
AGY

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automatic CLIA Analyzer
Shine i6000
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.